Aller au contenu principal
Profil bibliographique

Rita Vanbever

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

120Publications signalées
5370Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Inhalation and Respiratory Drug DeliveryMicrobial Inactivation MethodsAdvancements in Transdermal Drug DeliveryNeonatal Respiratory Health ResearchMicrofluidic and Bio-sensing Technologies

Les publications récentes

Accès ouvert 2026 article OpenAlex

Microliter-scale in vitro aerosol-cell delivery of inhalable antisense oligonucleotide (aso) induces “Burst-like” Pharmacokinetics

Pramod Kumar, Ashesh Chakraborty, Elias Richter, Lin Yang et autres

Unlike traditional submerged cell cultures, nebulized drug delivery to air-liquid interface (ALI)-cultured lung cells provides a clinically relevant route for in vitro testing of inhalable drugs. Current nebulizer systems deliver non-physiologically large drug volumes. Here, we introduce the Cloud MAX technology, characterize …

de, fr, be (code pays fourni par la source)

0 citations International Journal of Pharmaceutics X
Accès ouvert 2026 article OpenAlex

Enzymes-enhanced antibiotic therapy reduces biofilms to undetectable levels in an implant-associated infection model

Randy Buzisa Mbuku, Hervé Poilvache, Loïc Maigret, Rita Vanbever et autres

Implant-associated infections caused by biofilm-forming bacteria, such as Staphylococcus aureus , remain a major clinical challenge due to their high tolerance to conventional antibiotic therapies. We report a dual-targeted therapeutic strategy that combines a tri-enzymatic cocktail designed to degrade key components of …

be (code pays fourni par la source)

2 citations npj Biofilms and Microbiomes
Accès ouvert 2025 article OpenAlex

Synthesis and in vitro evaluation of polyethylene glycol-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension

Bernard Učakar, Frédéric Perros, Raphaël Frédérick, Rita Vanbever

Treprostinil (TRE) is a prostacyclin analogue approved for the treatment of pulmonary arterial hypertension (PAH). Despite its effectiveness, TRE has a short half-life, necessitating frequent or continuous administration to maintain therapeutic levels while minimizing adverse effects. To improve pharmacokinetics and pulmonary targeting …

be, fr (code pays fourni par la source)

1 citation European Journal of Pharmaceutical Sciences
Accès ouvert 2025 article OpenAlex

Targeting Staphylococcus aureus biofilm-related infections on implanted material with a novel dual-action thermosensitive hydrogel containing vancomycin and a tri-enzymatic cocktail: in vitro and in vivo studies

Randy Buzisa Mbuku, Hervé Poilvache, Loïc Maigret, Rita Vanbever et autres

Implant-associated infections remain a critical challenge due to the presence of biofilm-forming bacteria, which enhance tolerance to conventional treatments. This study investigates the efficacy of a tri-enzymatic cocktail (TEC; DNA/RNA endonuclease, endo-14-β-D-glucanase, β- N -acetylhexosaminidase) targeting biofilm matrix components combined with supratherapeutic …

be (code pays fourni par la source)

10 citations Biofilm
Accès ouvert 2024 article OpenAlex

Enzymatic, structural, and biophysical characterization of a single‐domain antibody (VHH) selectively and tightly inhibiting neutrophil elastase and exhibiting favorable developability properties

Paola Redeghieri, Joël Moray, Frédéric Kerff, Sophie Gohy et autres

Abstract Human neutrophil elastase (hNE), a serine protease released by neutrophils during inflammation, plays a major role in the pathophysiology of several conditions especially in inflammatory lung diseases. Its inhibition constitutes, therefore, a promising therapeutic strategy to combat these diseases. In this …

be (code pays fourni par la source)

0 citations Protein Science
Accès ouvert 2023 article OpenAlex

Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study

Sohaib Mahri, Tobias Wilms, Paul Hagedorm, Marie‐Julie Guichard et autres

Recombinant human deoxyribonuclease I (rhDNase, Pulmozyme®) is the most frequently used mucolytic agent for the symptomatic treatment of cystic fibrosis (CF) lung disease. Conjugation of rhDNase to polyethylene glycol (PEG) has been shown to greatly prolong its residence time in the lungs …

be, nl (code pays fourni par la source)

11 citations European Journal of Pharmaceutical Sciences
Accès ouvert 2022 article OpenAlex

Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono‐PEGylated alpha‐1 antitrypsin

Xiao Liu, Kobenan Guy Wilfried Kouassi, Rita Vanbever, Mireille Dumoulin

Conjugation to polyethylene glycol (PEG) is a widely used approach to improve the therapeutic value of proteins essentially by prolonging their body residence time. PEGylation may however induce changes in the structure and/or the stability of proteins and thus on their function(s). …

be (code pays fourni par la source)

17 citations Protein Science

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.